Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients Treated for Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04742101
What this trial is testing

Phase I/II Trial of S65487 Plus Azacitidine in Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Institut de Recherches Internationales Servier 57
Testing effectiveness (Phase 2)Study completedNCT00262860
What this trial is testing

Bortezomib and Gemcitabine Hydrochloride in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma

Who this might be right for
Lymphoma
University of Rochester 18
Not applicableEnded earlyNCT01053546
What this trial is testing

Effects of Swallowing Exercises on Patients Undergoing Radiation Treatment for Head and Neck Cancer

Who this might be right for
Head and Neck CancerStage I Hypopharyngeal CancerStage I Laryngeal Cancer+10 more
Wake Forest University Health Sciences 14
Early research (Phase 1)Study completedNCT00059761
What this trial is testing

Chemotherapy Combined With Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Radiation Therapy Oncology Group 36
Not applicableStudy completedNCT06451042
What this trial is testing

FET-PET/MRI Based Treatment Planning for Glioblastoma Multiforme in Post-Surgical Patients (FET-TREAT)

Who this might be right for
Glioblastoma Multiforme
Sunnybrook Health Sciences Centre 11
Testing effectiveness (Phase 2)Ended earlyNCT00017069
What this trial is testing

Arsenic Trioxide and Dexamethasone in Treating Patients With Recurrent or Refractory Stage II or Stage III Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
CTI BioPharma
Not applicableStudy completedNCT01679054
What this trial is testing

Cost-minimization Analysis of Gastric Cancer Treatments in Hong Kong

Who this might be right for
Gastric Cancer
Vivian Wing Yan Lee 58
Not applicableLooking for participantsNCT05904782
What this trial is testing

Development of Brief Positive Affect Treatment (PAT) for Caregivers of Patients With Advanced Cancer

Who this might be right for
Cancer
M.D. Anderson Cancer Center 150
Large-scale testing (Phase 3)Study completedNCT02292446
What this trial is testing

Expanded Treatment Protocol (ETP) of Ruxolitinib in Patients With Polycythemia Vera Who Were Hydroxyurea Resistant or Intolerant and for Whom no Treatment Alternatives Was Available.

Who this might be right for
Polycythemia Vera
Novartis Pharmaceuticals 161
Not applicableUnknownNCT02686203
What this trial is testing

Evaluate the Effectiveness of Low Level Laser Therapy (LLT) Combined With Acupuncture

Who this might be right for
Cancer
Erika Carmel ltd 30
Early research (Phase 1)Study completedNCT02171702
What this trial is testing

Dose Escalation Study of Oral Treatment With BIBW 2992 in Patients With Advanced Solid Tumours

Who this might be right for
Neoplasms
Boehringer Ingelheim 53
Early research (Phase 1)Ended earlyNCT00313053
What this trial is testing

Study of mAb 216 With Chemotherapy for Treatment of Pediatric Relapsed or Refractory B-progenitor Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia, Lymphocytic, AcuteLeukemiaAcute Lymphoid Leukemia (ALL)
Clare Twist 4
Testing effectiveness (Phase 2)Study completedNCT00002937
What this trial is testing

Paclitaxel With or Without PSC 833 in Treating Patients With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
City of Hope Medical Center 70
Testing effectiveness (Phase 2)Active Not RecruitingNCT05994001
What this trial is testing

Candonilimab in Combination With LM-302 for Claudin 18.2 Positive-advanced Biliary Tract Cancer After Failure of Standard of Chemotherapy and PD1/PD-L1 Antibody

Who this might be right for
Biliary Tract CancerCandonilimabClaudin 18.2
Shanghai Zhongshan Hospital 78
Testing effectiveness (Phase 2)Study completedNCT03472053
What this trial is testing

BIO-11006 in the Treatment of Advanced Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer Stage IIIB
BioMarck Pharmaceuticals, Ltd. 60
Not applicableStudy completedNCT02346253
What this trial is testing

High-Dose Brachytherapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaStage I Prostate CancerStage IIA Prostate Cancer+2 more
Stanford University 146
Testing effectiveness (Phase 2)UnknownNCT00411853
What this trial is testing

Efficacy of FWGE in Combination With Hormone Therapy for the Treatment of Hormone-Refractory Prostate Cancer Patients

Who this might be right for
Hormone Refractory Prostate Cancer
Sheba Medical Center 60
Testing effectiveness (Phase 2)UnknownNCT00637637
What this trial is testing

External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases

Who this might be right for
Cancer
Oncology Institute of Southern Switzerland 60
Large-scale testing (Phase 3)Study completedNCT00003057
What this trial is testing

Octreotide Compared With Loperamide Hydrochloride for Chemotherapy-Related Diarrhea in Patients With Colorectal Cancer

Who this might be right for
Colorectal CancerDiarrhea
Eastern Cooperative Oncology Group 500
Early research (Phase 1)Study completedNCT00404339
What this trial is testing

Vaccine Therapy in Treating Patients With Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Robert Ferris 17
Next Page